Home/Sanara MedTech/Tyler Palmer
TP

Tyler Palmer

Chief Corporate Development and Strategy Officer

Sanara MedTech

Sanara MedTech Pipeline

DrugIndicationPhase
CellerateRX® GelSurgical/Wound ManagementApproved
CellerateRX® Surgical PowderSurgical/Wound ManagementApproved
BIASURGE® Advanced Surgical SolutionSurgical IrrigationApproved
FORTIFY TRG® Tissue Repair GraftSoft Tissue RepairApproved
FORTIFY FLOWABLE® Extracellular MatrixSoft Tissue RepairApproved
TEXAGEN® Amniotic Membrane AllograftWound and Tissue RepairApproved
ALLOCYTE® Plus Advanced Viable Bone MatrixBone GraftingApproved
BiFORM® Bioactive Moldable MatrixBone Void FillingApproved